• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

An Insider Look at Top Deals from 2023

Monday, June 03, 2024
Breakout Session
Business Development and Finance
29AB
Few things can dominate the biotech news like a major acquisition – and for good reason. Not only do these deals reward innovation and spark excitement for new investments, but they move promising and proven treatments into larger organizations that can deliver them quickly to patients on a global scale. In this session, executives from three of the largest acquisitions of 2023 will share the deeper stories behind their deals. Moderated by a veteran biotech communicator, this session will explore topics from deal origins to negotiations, and from announcement to integration. In addition, these biotech leaders will share the lessons they learned along the way.
Moderator
Carin Canale-Theakston
Executive Biotech Advisor
Inizio
Speakers
Mark McKenna
CEO
Mirador Therapeutics
Enoch Kariuki, PharmD
President
Endeavor Biomedicines
Ken Song, MD
former CEO
RayzeBio
Remy Durand
Vertex
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS